Pagnani Giulio, Palma Angela, Bozza Fabrizio, Marsigli Rossi Lombardi Camilla, Becelli Roberto
Maxillofacial Surgery Unit, Department of Odontostomatological and Maxillofacial Sciences, University of Rome "La Sapienza", University Hospital Policlinico Umberto I, 00161 Rome, Italy.
Maxillofacial Surgery Unit, NESMOS Department, Faculty of Medicine and Psychology, S. Andrea Hospital, University of Rome "La Sapienza", 00189 Rome, Italy.
J Clin Med. 2025 Jun 26;14(13):4541. doi: 10.3390/jcm14134541.
Pleomorphic adenomas (PAs) are the most common salivary gland tumors, with a known risk of recurrence, especially after inadequate surgical excision. Understanding how surgical approach influences recurrence remains essential to optimize management. This study aimed to synthesize recurrence rates of PAs based on different surgical techniques and to illustrate the implications of surgical strategy through a representative case of multifocal deep lobe recurrence. A systematic review was conducted according to PRISMA 2020 guidelines. Three electronic databases (PubMed, Cochrane, and Google Scholar) were searched for studies published in the last ten years, reporting recurrence rates of PAs by surgical approach. Data were extracted on recurrence, complications, and tumor characteristics. Additionally, a complex clinical case of recurrent deep lobe PA (DLPA) was presented to contextualize the findings. Fifteen studies were included, comprising a total of 2095 patients. Recurrence rates were 3.27% after extracapsular dissection (ED), 0.73% after partial superficial parotidectomy (PSP), and 2.41% after superficial parotidectomy (SP). Recurrent PA (RPA) is often multifocal and associated with increased risks of facial nerve palsy and positive surgical margins. The presented case involved five surgical procedures, with ultimate total parotidectomy and facial nerve preservation despite infiltrative recurrence in the prestyloid space. Techniques such as ED and PSP have demonstrated their efficacy and safety compared to more invasive approaches, although their application should be carefully evaluated based on tumor size and location. RPA remains a challenging entity to treat. Avoiding outdated techniques and ensuring evidence-based decision making may improve long-term outcomes in PA management.
多形性腺瘤(PAs)是最常见的涎腺肿瘤,已知有复发风险,尤其是手术切除不充分后。了解手术方式如何影响复发对于优化治疗至关重要。本研究旨在综合基于不同手术技术的多形性腺瘤复发率,并通过一个多灶性深叶复发的代表性病例来说明手术策略的影响。根据PRISMA 2020指南进行了系统评价。检索了三个电子数据库(PubMed、Cochrane和谷歌学术),以查找过去十年发表的按手术方式报告多形性腺瘤复发率的研究。提取了关于复发、并发症和肿瘤特征的数据。此外,还介绍了一例复发性深叶多形性腺瘤(DLPA)的复杂临床病例,以将研究结果置于实际背景中。纳入了15项研究,共2095例患者。囊外剥离术(ED)后复发率为3.27%,部分腮腺浅叶切除术(PSP)后为0.73%,腮腺浅叶切除术(SP)后为2.41%。复发性多形性腺瘤(RPA)通常为多灶性,且与面神经麻痹和手术切缘阳性风险增加相关。所介绍的病例涉及五次手术,尽管茎突前间隙有浸润性复发,但最终还是进行了全腮腺切除术并保留了面神经。与更具侵入性的手术方法相比,ED和PSP等技术已证明了其有效性和安全性,尽管应根据肿瘤大小和位置仔细评估其应用。RPA仍然是一个具有挑战性的治疗实体。避免使用过时的技术并确保基于证据的决策制定可能会改善多形性腺瘤治疗的长期结果。